#USA #Aventura #Nuvo Intl Group #Rural Health Transformation Program #INVU™

Nuvo Unveils Application Support for RHTP

As the October 30, 2026 deadline for the Rural Health Transformation Program (RHTP) approaches, Nuvo Intl Group Inc. has made a significant announcement offering rural healthcare providers essential support. This initiative provides a comprehensive application support package aimed at assisting eligible hospitals, clinics, and obstetric practices in accessing federal funds for at-home fetal monitoring using their pioneering product, INVU™.

Streamlined Application Process

Nuvo's support package is tailored to ease the significant burden of navigating the RHTP application process. It encompasses a clinical evidence file, procurement support materials for sole-source applications, a ready-made budget template, and specific guidance on state eligibility criteria. This strategic support allows healthcare providers to collaborate with Nuvo's experienced team, significantly reducing the time and complexity associated with document preparation for their submissions.

Dr. Nadav Schwartz, a prominent figure in obstetrics and a member of Nuvo's Advisory Board, emphasized the transformative potential of remote fetal monitoring in underserved communities. He noted that INVU™ enables clinicians to provide continuous oversight of high-risk pregnancies, a vital advancement that minimizes the need for patients to travel for monitoring sessions. This approach not only improves clinical outcomes but also directly aligns with the objectives of the RHTP to enhance access to critical maternal care.

Getting Started with RHTP Funding

Providers eager to tap into the RHTP funding can easily reach out to Nuvo via their official website, nuvocares.com, to request the application support package. Nuvo's dedicated team will assist in determining eligibility, outlining the appropriate state program pathway, and supplying the necessary documentation for a successful application.

With a substantial $50 billion being allocated to strengthen rural healthcare infrastructure, a spotlight on maternity care has emerged as a key priority. However, the commitment deadline is approaching rapidly, highlighting the necessity for providers to act swiftly. Given that state review cycles can often span 60 to 120 days, the window for project submissions is limited.

Laurence Klein, CEO of Nuvo, voiced the company's resolve to eliminate obstacles that rural providers face when accessing available funding. Many expressed their awareness of available resources but felt overwhelmed by the paperwork involved. Nuvo’s goal is to facilitate a smooth transition from interest to application, ensuring timely access to essential funding.

Addressing Maternity Care Challenges

Access to maternal healthcare is a pressing issue in rural parts of America. Alarmingly, one in three U.S. counties lacks an OB provider or birthing facility, leading to roughly 500,000 rural births each year. The maternal mortality rates in rural areas are notably higher than in urban settings, further emphasizing the urgency for effective solutions.

INVU™ serves as a practical answer to these challenges, providing FDA-cleared wearable technology that enables pregnant individuals to conduct clinical-grade fetal monitoring in their own homes or workplaces, all under the vigilant guidance of healthcare providers. This innovative approach significantly alleviates the necessity for patients to undertake lengthy journeys for routine check-ups, thereby enhancing access to maternal care in remote locations.

Rapid Deployment and Integration

Nuvo's operational model is designed for quick deployment. After initial approval and contracting, Nuvo will oversee staff training, patient onboarding, and seamless integration into existing clinical workflows and electronic health record systems. Most healthcare sites can expect to commence patient care within two to four weeks after approval.

The real-world application of INVU™ has demonstrated notable benefits, including reduced appointment wait times, high rates of successful monitoring from home, decreased unnecessary emergency visits through proactive remote triage, and high satisfaction among healthcare providers. This underscores the success and efficiency of integrating advanced technology into maternal healthcare practices.

About Nuvo Intl Group Inc.

Nuvo Intl Group Inc. stands at the forefront of transforming pregnancy care through groundbreaking wearable monitoring solutions and data-driven insights. With its flagship technology, INVU™, Nuvo is redefining the landscape of remote maternal and fetal monitoring, long extending clinical care beyond traditional settings and into the home environment.

For further details or inquiries, visit nuvocares.com or contact [email protected].